Breast Cancer: Targets and Therapy
Volume 16, 2024 - Issue
Open access
263
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors
Suheyla Ekemen1 Vocational School of Health Services, Acibadem University, Istanbul, Turkey;2 Division of Malaria Immunology, Department of Microbiology and Immunology, Institute of Medical Science (IMSUT), the University of Tokyo, Tokyo, JapanCorrespondence[email protected] [email protected]
https://orcid.org/0000-0001-7135-0233View further author information
Ebru Bilir3 Residency Program, Bahcesehir University School of Medicine, Istanbul, TurkeyView further author information
, Hagar Elsayed Akram Soultan3 Residency Program, Bahcesehir University School of Medicine, Istanbul, TurkeyView further author information
, Sadia Zafar3 Residency Program, Bahcesehir University School of Medicine, Istanbul, Turkey
https://orcid.org/0009-0001-9996-2351View further author information
Figen Demir4 Department of Public Health, Acibadem University School of Medicine, Istanbul, TurkeyView further author information
, Babek Tabandeh5 Department of General Surgery, Bahcesehir University School of Medicine, Istanbul, TurkeyView further author information
, Sadik Toprak6 Department of Forensic Medicine, Istanbul University School of Medicine, Istanbul, Turkey
https://orcid.org/0000-0002-8065-1334View further author information
Ozlem Yapicier7 Department of Pathology, Bahcesehir University School of Medicine, Istanbul, TurkeyView further author information
& Cevayir Coban2 Division of Malaria Immunology, Department of Microbiology and Immunology, Institute of Medical Science (IMSUT), the University of Tokyo, Tokyo, Japan;8 Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Japan;9 International Vaccine Design Center, Institute of Medical Science (IMSUT), the University of Tokyo, Tokyo, JapanView further author information
show all
Pages 1-13
|
Received 24 Oct 2023, Accepted 21 Dec 2023, Published online: 02 Jan 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.